Literature DB >> 21439437

Epidemiology of multiple sclerosis.

Sreeram V Ramagopalan1, A Dessa Sadovnick.   

Abstract

Multiple sclerosis (MS) is the most common disease of the central nervous system that causes permanent disability in young adults. Based on strong circumstantial evidence, MS is considered to be putative autoimmune disorder, but much remains to be understood about the etiology and clinical onset of the disease. It seems unlikely that MS results from a single causative event, but rather is the result of genetic and environmental factors and the interactions thereof. This article discusses the epidemiology of MS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21439437     DOI: 10.1016/j.ncl.2010.12.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  33 in total

1.  Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.

Authors:  Dimitry N Krementsov; Rajkumar Noubade; Julie A Dragon; Kinya Otsu; Mercedes Rincon; Cory Teuscher
Journal:  Ann Neurol       Date:  2014-01       Impact factor: 10.422

2.  Sex/gender influences on the nervous system: Basic steps toward clinical progress.

Authors:  Claudette Elise Brooks; Janine Austin Clayton
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis.

Authors:  Leslie S Wilson; Aimee Loucks; Gregory Gipson; Lixian Zhong; Christine Bui; Elizabeth Miller; Mary Owen; Daniel Pelletier; Douglas Goodin; Emmanuelle Waubant; Charles E McCulloch
Journal:  Int J MS Care       Date:  2015 Mar-Apr

Review 4.  Multiple sclerosis outcomes after cancer immunotherapy.

Authors:  Catherine R Garcia; Rani Jayswal; Val Adams; Lowell B Anthony; John L Villano
Journal:  Clin Transl Oncol       Date:  2019-02-20       Impact factor: 3.405

5.  Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Seyedeh Nastaran Seyed Saadat; Seyedeh Parand Nabizadeh
Journal:  Neurol Sci       Date:  2013-12-10       Impact factor: 3.307

6.  Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.

Authors:  Dimitry N Krementsov; Laure K Case; William F Hickey; Cory Teuscher
Journal:  FASEB J       Date:  2015-04-27       Impact factor: 5.191

7.  Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.

Authors:  Niyaz Mohammadzadeh Honarvar; Mohammad Hossein Harirchian; Mina Abdolahi; Elahe Abedi; Sama Bitarafan; Fariba Koohdani; Feridoun Siassi; Mohammad Ali Sahraian; Reza Chahardoli; Mahnaz Zareei; Eisa Salehi; Maziyar Geranmehr; Ali Akbar Saboor-Yaraghi
Journal:  J Mol Neurosci       Date:  2016-04-28       Impact factor: 3.444

8.  Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.

Authors:  Caroline Bruun Helland; Trygve Holmøy; Pål Gulbrandsen
Journal:  Int J MS Care       Date:  2015 May-Jun

9.  Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.

Authors:  Behnam Khalilian; Soheila Madadi; Nima Fattahi; Beheshteh Abouhamzeh
Journal:  J Mol Histol       Date:  2020-11-27       Impact factor: 2.611

Review 10.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.